NMR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Nomura Holdings Inc (NMR) is not a strong buy at the moment for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. While there are some positive catalysts, the company's recent financial performance, lack of strong trading signals, and neutral sentiment from hedge funds and insiders suggest a cautious approach. The pre-market price drop and lack of strong upward momentum also indicate that waiting for a better entry point may be prudent.
The MACD histogram is positive at 0.0518 and expanding, indicating a mild bullish trend. However, RSI at 46.117 is neutral, and moving averages are converging, showing no clear direction. The stock is trading near its pivot level of 7.711, with key resistance at 7.988 and support at 7.434. Pre-market price is down 2.07%, which reflects short-term weakness.
Japan's improving business conditions, weaker yen benefiting exporters, and favorable economic outlook may provide long-term tailwinds for Nomura Holdings.
The company's financials for Q2 2026 show declines in revenue (-5.41% YoY), net income (-5.35% YoY), and EPS (-4.55% YoY). Additionally, the pre-market price drop of 2.07% and neutral sentiment from hedge funds and insiders indicate a lack of strong buying interest.
In Q2 2026, Nomura's revenue dropped by 5.41% YoY to 7.88 billion, net income fell by 5.35% YoY to 624.5 million, and EPS declined by 4.55% YoY to 0.21. However, gross margin improved by 14.03% YoY to 44.39, indicating some operational efficiency gains.
JPMorgan recently upgraded Nomura to Overweight from Neutral with a price target increase to 1,440 yen, citing the strength of the company's core business. However, Goldman Sachs removed Nomura Shipbuilding from its APAC Conviction List earlier this year, reflecting mixed sentiment among analysts.
